Supplementary Materials

Supplementary Material for:

BPIFB1 Is a Lung-Specific Autoantigen Associated with Interstitial Lung Disease

Anthony K. Shum, Mohammad Alimohammadi, Catherine L. Tan, Mickie H. Cheng, Todd C. Metzger, Christopher S. Law, Wint Lwin, Jaakko Perheentupa, Helene Bour- Jordan, Jean Claude Carel, Eystein S. Husebye, Filippo De Luca, Christer Janson, Ravishankar Sargur, Noémie Dubois, Merja Kajosaari, Paul J. Wolters, Harold A. Chapman, Olle Kämpe, Mark S. Anderson*

*Corresponding author. E-mail: manderson@diabetes.ucsf.edu

Published 9 October 2013, Sci. Transl. Med. 5, 206ra139 (2013)
DOI: 10.1126/scitranslmed.3006998

This PDF file includes:

  • Fig. S1. ROC curve of BPIFB1 assay.
  • Fig. S2. Expression of BPIFB1 mRNA in normal human tissues by qPCR.
  • Fig. S3. Diagnoses of CTD-ILD patients.
  • Fig. S4. Diagnoses of idiopathic ILD patients.
  • Fig. S5. Baseline characteristics of ILD and non-ILD patients.
  • Fig. S6. IFN-α autoantibody assay in APS1 and non-APS1 ILD patients.
  • Fig. S7. Serum transfers of BPIFB9 autoantibodies.
  • Table S1. Clinical data for CTD-ILD patients with elevated BPIFB1 autoantibodies.
  • Table S2. Clinical data for idiopathic ILD patients with elevated BPIFB1 autoantibodies.

[Download PDF]